blarcamesine (Anavex 2-73) / Anavex  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
blarcamesine (Anavex 2-73) / Anavex
ATTENTION-AD, NCT04314934: OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Active, not recruiting
2b
450
Europe, Canada, RoW
ANAVEX2-73, Blarcamesine
Anavex Life Sciences Corp., Anavex Australia Pty Ltd., Anavex Germany GmbH
Alzheimer Disease
07/24
07/24

Download Options